Nanobiotix S.A.
NBTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001760854
No open-market purchases or sales by Nanobiotix S.A. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $218.4M in total; no superinvestor holds it.
Other share classesNNBXF
Holders of 5% or more of NBTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nanobiotix S.A., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 13G | 8.90%4.23M shares | New | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Nanobiotix S.A., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 17, 20254:30 PM ET | Invus Global Management, LLCand 4 others | 13G | 8.90%4.23M shares | New | Dec 31, 2023 | SEC |
| Feb 12, 20259:11 AM ET | Baillie Gifford & Co | 13G/A | 4.10%1.92M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nanobiotix S.A. shares.
No Form 144 notices for Nanobiotix S.A. are on file.